Comparison of the Effects of Alendronate and Alfacalcidol on Hip Bone Mineral Density and Bone Turnover in Japanese Men Having Osteoporosis or Osteopenia with Clinical Risk Factors for Fractures

키워드

참고문헌 (36)

1. Liberman UA, "Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis, in The Alendronate Phase III Osteoporosis Treatment Study Group", N Engl J Med, 333, pp.1437~1443 (1995)
2. Black DM, "Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures, in Fracture Intervention Trial Research Group", Lancet, 348, pp.1535~1541 (1996)
3. Cummings SR, "Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial", JAMA, 280, pp.2077~2082 (1998)
4. Bone HG, "Ten years’ experience with alendronate for osteoporosis in postmenopausal women", N Engl J Med, 350, pp.1189~1199 (2004)
5. Black DM, "Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Longterm Extension (FLEX): a randomized trial", JAMA, 296, pp.2927~2938 (2006)
6. Cranney A, "Osteoporsis Methodology Group and The Osteoporosis Research Advisory Group. Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis", Endocr Rev, 23, pp.570~578 (2002)
7. Papapoulos SE, "Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women", Osteoporos Int, 16, pp.468~474 (2005)
8. Liberman UA, "Hip and non-spine fracture risk reductions differ among antiresorptive agents: Evidence from randomised controlled trials", Int J Clin Pract, 60, pp.1394~1400 (2006)
9. Hochberg MC, "Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures", J Bone Miner Res, 20, pp.971~976 (2005)
10. Orwoll E, "Alendronate for the treatment of osteoporosis in men", N Engl J Med, 343, pp.604~610 (2000)
11. Kanis JA, "The components of excess mortality after hip fracture", Bone, 32, pp.468~473 (2003)
12. Tsuboi M, "Mortality and mobility after hip fracture in Japan: a ten-year follow-up", J Bone Joint Surg Br, 89, pp.461~466 (2007)
13. Hasegawa Y, "Risk of mortality following hip fracture in Japan", J Orthop Sci, 12, pp.113~117 (2007)
14. Hochberg MC, "Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents", J Clin Endocrinol Metab, 87, pp.1586~1592 (2002)
15. Bauer DC, "Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial", J Bone Miner Res, 19, pp.1250~1258 (2004)
16. Ringe JD, "Treatment of male osteoporosis: recent advances with alendronate", Osteoporos Int, 13, pp.195~199 (2002)
17. Ringe JD, "Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study", Rheumatol Int, 26, pp.427~431 (2006)
18. Ringe JD, "Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial)", Rheumatol Int, 27, pp.425~434 (2007)
19. Gonnelli S, "Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study", Calcif Tissue Int, 73, pp.133~139 (2003)
20. Ringe JD, "Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm study", Rheumatol Int, 24, pp.110~113 (2004)
21. Orimo H, "Diagnostic criteria of primary osteoporosis", J Bone Miner Metab, 16, pp.139~150 (1998)
22. Orimo H, "Diagnostic criteria for primary osteoporosis: year 2000 revision", J Bone Miner Metab, 19, pp.331~337 (2001)
23. Kanis JA, "Assessment of fracture risk", Osteoporos Int, 16, pp.581~589 (2005)
24. Shiraki M, "A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis, in The Alendronate Phase III Osteoporosis Treatment Research Group", Osteoporos Int, 10, pp.183~192 (1990)
25. Kushida K, "The efficacy of alendronate in reducing the risk for vertebral fracture in Japanese patients with osteoporosis: a randomized, double-blind, active-controlled, double-dummy trial", Curr Ther Res, 63, pp.606~620 (2002)
26. Orimo H, "Effects of 1 alpha-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis", Calcif Tissue Int, 54, pp.370~376 (1994)
27. Nishizawa Y, "Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004)", J Bone Miner Metab, 23, pp.97~104 (2005)
28. Seeman E, "Unresolved issues in osteoporosis in men", Rev Endocr Metab Disord, 2, pp.45~64 (2001)
29. Resch H, "Bone mass and biochemical parameters of bone metabolism in men with spinal osteoporosis", Eur J Clin Invest, 22, pp.542~545 (1992)
30. Sharp CA, "Accurate prediction of spinal osteoporosis in men using a biochemical measure of collagen balance", Bone, 15, pp.243~ (1994)
31. Shiraishi A, "Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen", J Bone Miner Res, 15, pp.770~779 (2000)
32. Schacht E, "Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroidinduced osteoporosis with alfacalcidol", Calcif Tissue Int, 65, pp.317~327 (1999)
33. Shiraishi A, "A comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovariectomized rat model of osteoporosis", Calcif Tissue Int, 71, pp.69~79 (2002)
34. Bischoff-Ferrari HA, "Effect of Vitamin D on falls: a meta-analysis", JAMA, 291, pp.1999~2006 (2004)
35. Jesudason D, "Relationship between serum 25-hydroxy vitamin D and bone resorption markers in vitamin D insufficiency", Bone, 31, pp.626~630 (2002)
36. de Nijs RN, "Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis", N Engl J Med, 355, pp.675~684 (2006)

관련 논문AI추천